Ionis Pharmaceuticals | IONS - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Agios Pharmaceuticals USD 834.84M 107.21M 2026-03
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
Arrowhead Research USD 1.84B 665.36M 2026-03
Astellas Pharma JPY 1.42T 19.35B 2026-03
BioCryst Pharmaceuticals USD 373.62M 30.72M 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Celltrion KRW 470.6B 5.07T 2025-12
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Esperion Therapeutics USD 459.46M 3.11M 2026-03
Exelixis USD 1.21B 234.65M 2026-03
Halozyme Therapeutics USD 1B 177.83M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
Kangmei Pharma CNY 6.8B 225.83M 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Moderna USD 5.77B 774M 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Neurocrine Biosciences USD 2.44B 86.6M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Omeros USD 69.65M 26.53M 2025-06
OPKO Health USD 581.88M 45.25M 2025-12
Organigram Holdings CAD 256.54M 28.35M 2025-12
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pfizer USD 42.82B 76M 2026-03
Pharma Mar EUR 273.45M 9.96M 2026-03
PTC Therapeutics USD 2.25B 19.94M 2026-03
Qiagen NV USD 2B 535.87M 2025-12
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Sartorius EUR 1.92B 157.2M 2026-03
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tilray USD 729.32M 28.18M 2025-09
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03
Zealand Pharma A/S 15.67B 950.94M 2025-12
Zz Pientze Pharmaceu CNY 11.43B 728.95M 2026-03